Literature DB >> 10336184

Cyclosporin-A inhibits lipid peroxidation after spinal cord injury in rats.

A Diaz-Ruiz1, C Rios, I Duarte, D Correa, G Guizar-Sahagun, I Grijalva, A Ibarra.   

Abstract

Besides its immunosuppressive/anti-inflammatory activity, cyclosporin-A (CsA) may protect damaged tissues from lipid peroxidation (LP) by free radicals. To determine the effect of CsA on LP spinal cord (SC) injury, Wistar rats were treated with either vehicle or CsA (2.5 mg/kg per 12 h i.p.) 1, 2, 6 or 12 h after SC trauma by T8-T9 spinal cord contusion, analyzing LP 24 h after injury at the lesion site by the lipid fluorescent products formation method. CsA significantly diminished LP to levels below control values after contusion (P < 0.05). The greater inhibition was observed when CsA was given during the first 6 h after injury, furthermore, animals showed a significant clinical improvement. Results show that CsA may be beneficial to injured tissue by inhibiting the levels of LP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336184     DOI: 10.1016/s0304-3940(99)00255-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

Review 1.  Antioxidant therapies for acute spinal cord injury.

Authors:  Edward D Hall
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 2.  Molecular targets in spinal cord injury.

Authors:  Stefan Klussmann; Ana Martin-Villalba
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

3.  Acute alterations of glutamate, glutamine, GABA, and other amino acids after spinal cord contusion in rats.

Authors:  Araceli Diaz-Ruiz; Hermelinda Salgado-Ceballos; Sergio Montes; Valente Maldonado; Luis Tristan; Mireya Alcaraz-Zubeldia; Camilo Ríos
Journal:  Neurochem Res       Date:  2006-12-09       Impact factor: 3.996

4.  Anti-Apoptotic Effects of Dapsone After Spinal Cord Injury in Rats.

Authors:  Camilo Ríos; Sandra Orozco-Suarez; Hermelinda Salgado-Ceballos; Marisela Mendez-Armenta; Concepción Nava-Ruiz; Iván Santander; Veronica Barón-Flores; Nadia Caram-Salas; Araceli Diaz-Ruiz
Journal:  Neurochem Res       Date:  2015-05-01       Impact factor: 3.996

Review 5.  Targeting mitochondrial function for the treatment of acute spinal cord injury.

Authors:  Melanie L McEwen; Patrick G Sullivan; Alexander G Rabchevsky; Joe E Springer
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

6.  Uric acid protects against secondary damage after spinal cord injury.

Authors:  Gwen S Scott; Salvatore Cuzzocrea; Tiziana Genovese; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

7.  Cyclosporin-A inhibits constitutive nitric oxide synthase activity and neuronal and endothelial nitric oxide synthase expressions after spinal cord injury in rats.

Authors:  Araceli Diaz-Ruiz; Paula Vergara; Francisca Perez-Severiano; Jose Segovia; Gabriel Guizar-Sahagún; Antonio Ibarra; Camilo Ríos
Journal:  Neurochem Res       Date:  2005-02       Impact factor: 3.996

8.  Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury.

Authors:  Sabina Luchetti; Kevin D Beck; Manuel D Galvan; Richard Silva; Brian J Cummings; Aileen J Anderson
Journal:  J Neurotrauma       Date:  2010-02       Impact factor: 5.269

9.  Post-Injury Treatment with NIM811 Promotes Recovery of Function in Adult Female Rats after Spinal Cord Contusion: A Dose-Response Study.

Authors:  Joe E Springer; Nishant P Visavadiya; Patrick G Sullivan; Edward D Hall
Journal:  J Neurotrauma       Date:  2017-11-06       Impact factor: 5.269

10.  Effect of cyclosporin A on functional recovery in the spinal cord following contusion injury.

Authors:  Siobhan S McMahon; Silke Albermann; Gemma E Rooney; Cathal Moran; Jacqueline Hynes; Yolanda Garcia; Peter Dockery; Timothy O'Brien; Anthony J Windebank; Frank P Barry
Journal:  J Anat       Date:  2009-06-24       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.